Compare Pfizer with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs PIRAMAL ENTERPRISES - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER PIRAMAL ENTERPRISES PFIZER/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 39.4 17.6 223.4% View Chart
P/BV x 6.7 1.2 549.4% View Chart
Dividend Yield % 0.5 1.9 26.9%  

Financials

 PFIZER   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    PFIZER
Mar-19
PIRAMAL ENTERPRISES
Mar-19
PFIZER/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3,8403,303 116.3%   
Low Rs2,0801,797 115.8%   
Sales per share (Unadj.) Rs455.0716.5 63.5%  
Earnings per share (Unadj.) Rs93.879.7 117.7%  
Cash flow per share (Unadj.) Rs109.4107.9 101.4%  
Dividends per share (Unadj.) Rs22.5028.00 80.4%  
Dividend yield (eoy) %0.81.1 69.2%  
Book value per share (Unadj.) Rs658.21,477.5 44.5%  
Shares outstanding (eoy) m45.75184.45 24.8%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x6.53.6 182.8%   
Avg P/E ratio x31.632.0 98.7%  
P/CF ratio (eoy) x27.123.6 114.5%  
Price / Book Value ratio x4.51.7 260.6%  
Dividend payout %24.035.1 68.3%   
Avg Mkt Cap Rs m135,420470,292 28.8%   
No. of employees `0002.67.8 33.6%   
Total wages/salary Rs m3,23822,504 14.4%   
Avg. sales/employee Rs Th7,911.416,899.4 46.8%   
Avg. wages/employee Rs Th1,230.92,877.7 42.8%   
Avg. net profit/employee Rs Th1,630.71,879.9 86.7%   
INCOME DATA
Net Sales Rs m20,815132,153 15.8%  
Other income Rs m1,6743,128 53.5%   
Total revenues Rs m22,489135,281 16.6%   
Gross profit Rs m5,71266,290 8.6%  
Depreciation Rs m7145,202 13.7%   
Interest Rs m7344,097 0.2%   
Profit before tax Rs m6,59920,119 32.8%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3098,611 26.8%   
Profit after tax Rs m4,29114,701 29.2%  
Gross profit margin %27.450.2 54.7%  
Effective tax rate %35.042.8 81.7%   
Net profit margin %20.611.1 185.3%  
BALANCE SHEET DATA
Current assets Rs m27,167122,742 22.1%   
Current liabilities Rs m8,917310,810 2.9%   
Net working cap to sales %87.7-142.3 -61.6%  
Current ratio x3.00.4 771.5%  
Inventory Days Days6823 294.0%  
Debtors Days Days3039 77.5%  
Net fixed assets Rs m8,862116,904 7.6%   
Share capital Rs m458369 124.0%   
"Free" reserves Rs m29,656272,161 10.9%   
Net worth Rs m30,113272,530 11.0%   
Long term debt Rs m25270,196 0.0%   
Total assets Rs m39,400856,261 4.6%  
Interest coverage x91.51.5 6,284.9%   
Debt to equity ratio x01.0 0.1%  
Sales to assets ratio x0.50.2 342.3%   
Return on assets %11.16.9 161.3%  
Return on equity %14.25.4 264.1%  
Return on capital %22.112.4 178.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42815,200 2.8%   
Fx outflow Rs m7864,889 16.1%   
Net fx Rs m-35810,312 -3.5%   
CASH FLOW
From Operations Rs m978-115,975 -0.8%  
From Investments Rs m351-8,265 -4.2%  
From Financial Activity Rs m-1,099107,525 -1.0%  
Net Cashflow Rs m231-16,650 -1.4%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 4.0 187.5%  
FIIs % 4.9 26.6 18.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 16.5 143.6%  
Shareholders   85,207 93,274 91.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ALEMBIC LTD  SUN PHARMA  IPCA LABS  FDC LTD.  AUROBINDO PHARMA  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Power and Telecom Stocks Witness Buying(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

How to Buy Gold and Silver(Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Aug 7, 2020 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS